Clinical Trial Update: Effects of Copaxone in the Retinal Function in Diabetic Patients After Panphotocoagulation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating Copaxone (glatiramer acetate) for effects on retinal function in diabetic retinopathy after panphotocoagulation. The tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Drugs mentioned

• COPAXONE (GLATIRAMER ACETATE)

Snippet

Sponsor: Federal University of São Paulo | Conditions: Diabetic Retinopathy | Phase 4 | Status: UNKNOWN